Thu, Apr 27, 2017
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

V2 Capital opens long/short equity fund to outside investments

Tuesday, November 06, 2012

Bailey McCann, Opalesque New York:

Founded in 2004, V2 Capital relies on the expertise of Victor Viner who has over 25 years in the investments industry – buy-side and sell-side. Co-manager of the V2 Hedged Equity Fund, Victor has 25+ years of capital markets and trading experience including senior positions at UBS and Credit Suisse Group. Prior to founding V2 Capital, he co-founded and was President and CIO of Volaris Advisors, a multi-billion dollar AUM option strategy firm acquired by Credit Suisse Group in 2003.

After the financial crisis in 2008 and specifically the collapse of Lehman and Bear Stearns, V2’s clients along with many other investors became very concerned with single counterparty risk from trading over the counter options. V2’s advisory business primary traded OTC options that were used to enhance the underlying position’s yield, analogous to creating a synthetic dividend.

After the financial crisis, one of V2’s clients was Ken Langone, co-founder of Home Depot. After discussions with Ken and other clients, it became apparent that there was a real demand for a product that combines a portfolio of long high quality dividend paying equities combined with a short options overlay using customized index options. The equity selection is based on rigorous bottoms up analysis, diversifying exposure across each of the sectors in the S&P 500. The short call options are selected based on the current volatility environment and used to manage net expos......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Alternative asset firm YieldStreet surpasses $100m of loans funded in less than 8 quarters[more]

    Komfie Manalo, Opalesque Asia: Alternative asset investment platform YieldStreet reported that it has surpassed $100m in loans funded in less than eight quarters from accredited investors and single family offices. YieldStreet was founded by Milind Mehere and Michael Weisz. In a

  2. Investing - Investor appetite for high-growth IPOs to be tested, Apollo boosts fund's stock allowance for 'diamonds in the rough', Hedge funds uncertain over outlook for Hargreaves Lansdown[more]

    Investor appetite for high-growth IPOs to be tested From FT.com: The US listings market is poised for a busy week with deals that will test investors' appetite for high-growth - but lossmaking - companies. Eight new listings are scheduled for this week, the most since October of 2016,

  3. Hedge funds holding Puerto Rico bonds are looking at a long battle[more]

    Komfie Manalo, Opalesque Asia: Hedge funds which bought Puerto Rico's distressed debt bonds are facing the prospect of a long road ahead to recover their investments as the Caribbean island is attempting to use a U.S. Congress-approved rule that allows it to exploit a bankruptcy-like proceedings

  4. Other Voices: "Winner-take-all" dynamics and hedge fund investing[more]

    A growing stream of thinking in microeconomics is the concept of "winner-take-all" dynamics. The idea seems simple. A combination of networking economics and classic economies of scale creates situations where there are just a few dominant firms or economic agents who are able to capture significant

  5. Investing - How Chipotle's comeback attracted big data robots and value investors alike[more]

    From Forbes.com: When William Ackman's ailing hedge fund Pershing Square Capital Management bet $1 billion on shares in Chipotle Mexican Grill beginning in July 2016, the stakes couldn't have been higher. Pershing Square was reeling from what would eventually be a near $4 billion loss in drugmaker V